risperidone has been researched along with Cerebral Palsy in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Cerebral Palsy: A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Children with choreoathetoid cerebral palsy were enrolled after parental consent and given risperidone for six-month period along with standard care." | 7.88 | Effect of Risperidone on the Motor and Functional Disability in Children With Choreoathetoid Cerebral Palsy. ( Kamate, M; Metgud, D; Mittal, N, 2018) |
| "Children with choreoathetoid cerebral palsy were enrolled after parental consent and given risperidone for six-month period along with standard care." | 3.88 | Effect of Risperidone on the Motor and Functional Disability in Children With Choreoathetoid Cerebral Palsy. ( Kamate, M; Metgud, D; Mittal, N, 2018) |
| "A 19-year-old man with schizophrenia and underlying cerebral disease developed rapid-onset mania after risperidone was replaced with amisulpride." | 3.80 | Amisulpride-associated mania in a young adult with schizophrenia and cerebral disease. ( Chen, CY; Chen, TY; Chuang, WC; Kuo, SC; Yeh, YW, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamate, M | 1 |
| Mittal, N | 1 |
| Metgud, D | 1 |
| Chuang, WC | 1 |
| Chen, CY | 1 |
| Kuo, SC | 1 |
| Chen, TY | 1 |
| Yeh, YW | 1 |
2 other studies available for risperidone and Cerebral Palsy
| Article | Year |
|---|---|
Effect of Risperidone on the Motor and Functional Disability in Children With Choreoathetoid Cerebral Palsy.
Topics: Anti-Dyskinesia Agents; Cerebral Palsy; Child; Child, Preschool; Chorea; Dyskinesias; Female; Humans | 2018 |
Amisulpride-associated mania in a young adult with schizophrenia and cerebral disease.
Topics: Amisulpride; Antipsychotic Agents; Bipolar Disorder; Cerebral Palsy; Drug Administration Schedule; H | 2014 |